Why is the nanoscale special (or not) ? Fundamental properties and how it relates to the design of nano-enabled drug delivery systems

Nanotechnology Reviews

Volumn 2, Issue 2, 2013, Pages 171-199

  Otto, Daniel P ^b   De Villiers, Melgardt M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Nano enabled drug delivery; Nanoparticle; Nanotechnology; Physicochemical properties

Indexed keywords

BIOLOGICAL MATERIALS; CONTROLLED DRUG DELIVERY; ENERGY CONVERSION; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

BIOLOGICAL PROPERTIES; DRUG DELIVERY SYSTEM; FUNDAMENTAL PROPERTIES; INTERFACIAL INTERACTION; MACROSCOPIC LEVELS; NANO-DELIVERY SYSTEMS; PHYSICOCHEMICAL PROPERTY; SURFACE-TO-VOLUME RATIO;

TARGETED DRUG DELIVERY;

EID: 84896388835     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2012-0051     Document Type: Review

References (204)

1. Balzani V. Nanoscience and nanotechnology: a personal view of a chemist. Small 2005, 1, 278-283.
2. NNI. National Nanotechnology Initiative. Availabe at: http://www.nano.gov. Accessed on 1 September 2012.
3. Moghimi SM, Kissel T. Particulate nanomedicines. Adv. Drug Deliv. Rev. 2006, 58, 1451-1455.
4. Hughes GA. Nanostructure-mediated drug delivery. Nanomed. Nanotech. Biol. Med. 2005, 1, 22-30.
5. Roco MC. Nanotechnology: convergence with modern biology and medicine. Curr. Opin. Biotechnol. 2003, 14, 337-346.
6. Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicines. Biosystems 2002, 65, 123-138.
7. Xu XH, Brownlow WJ, Kyriacou SV, Wan Q, Viola JJ. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging. Biochemistry 2004, 43, 10400-10413.
8. Brayden DJ. Controlled release technologies for drug delivery. Drug Discov. Today 2003, 8, 976-978.
9. Ferrari M, Downing G. Medical nanotechnology. Shortening clinical trials and regulatory pathways ? BioDrugs 2005, 10, 203-210.
10. Feynman RP. There's plenty of room at the bottom. An invitation to enter a new field of physics. Eng. Sci. 1960, 23, 22-36.
11. Guisbiers G, Shirinyan AS, Wautelet M. The physics of macro-, micro-and nanomaterials. Phys. Mag. 2005, 27, 131-141.
12. Roduner E. Size matters: why nanomaterials are different. Chem. Soc. Rev. 2006, 35, 583-592.
13. Rao CNR, Kulkarni GU, Thomas PJ, Edwards PP. Size-dependent chemistry: properties of nanocrystals. Chem. Eur. J. 2002, 8, 28-35.
14. Yoffe AD. Low-dimensional systems: quantum size effects and electronic properties of semiconductor microcrystallites (zero-dimensional systems) and some quasi-two-dimensional systems. Adv. Phys. 1993, 42, 173-266.
15. Balandin AA. Nanophononics: phonon engineering in nanostructures and nanodevices. J. Nanosci. Nanotechnol. 2005, 5, 1015-1022.
16. Cahill DG, Ford WK, Goodson KE, Mahan GD, Majumdar A, Maris HJ, Merlin R, Phillpot SR. Nanoscale thermal transport. J. Appl. Phys. 2003, 93, 793-818.
17. Shakouri A. Nanoscale thermal transport and microrefrigerators on a chip. Proc. IEEE 2006, 94, 1613-1638.
18. Heeger AJ. Semiconducting and metallic polymers: the fourth generation of polymeric materials. Synth. Met. 2001, 125, 23-42.
19. Long Y, Zhang L, Chen Z, Huang K, Yang Y, Xiao H, Wan M, Jin A, Gu C. Electronic transport in single polyaniline and polypyrolle microtubes. Phys. Rev. B 2005, 71, 165412, 1-7.
20. Feast WJ, Tsibouklis J, Pouwer KL, Groenendaal L, Meijer EW. Synthesis, processing and material properties of conjugated polymers. Polymer 1996, 37, 5017-5047.
21. Spitalsky Z, Tasis D, Papagelis K, Galiotis C. Carbon nanotube composites: chemistry processing and electrical properties. Prog. Polym. Sci. 2010, 35, 357-401.
22. Untereker D, Lyu S, Schley J, Martinez G, Lohstreter L. Maximum conductivity of packed nanoparticles and their polymer composites. ACS Appl. Mater. Interfaces 2009, 1, 97-101.
23. Knite M, Teteris V, Polyakov B, Erts D. Electric and elastic properties of conductive polymeric nanocomposites on macroand nanoscales. Mater. Sci. Eng. C 2002, 19, 15-19.
24. Heeger AJ. Charge transfer in conducting polymers. Faraday Discuss. 1989, 88, 203-211.
25. Heeger AJ. Semiconducting polymers: the third generation. Chem. Soc. Rev. 2010, 39, 2354-2371.
26. Nord e n B, Krutmeijer E. The Nobel Prize in Chemistry, 2000: Conductive polymers. Availabe at: http://nobelprize.org/nobel-prizes/chemistry/laureates/2000/chemadv.pdf. Accessed on 1 September 2012.
27. Brezoi DV, Ion RM. Phase evolution induced by polypyrolle in iron oxide-polypyrolle nanocomposite. Sens. Actuators B 2005, 109, 171-175.
28. Long, YZ, Chen, Z, Gum, C, Wan M, Duvail, JC, Liu Z, Ringer, SP. A review on electronic properties of individual and conducting polymer nanotubes and nanowires. In Nanowires Science and Technology, Lupu, N, Ed., INTECH: Croatia, 2010, pp. 223-242.
29. Jin J, Wang Q, Haque MA. Length-scale effects on electrical and thermal transport in polyaniline thin films. Org. Electron. 2010, 11, 29-35.
30. Li C, Thostenson ET, Chou TW. Effect of nanotube waviness on the electrical conductivity of carbon nanotube-based composites. Compos. Sci. Technol. 2008, 68, 1445-1452.
31. Zeng Y, Liu P, Du J, Zhao L, Ajayan PM, Cheng HM. Increasing the electrical conductivity of carbon nanotube/polymer composites by using weak nanotube-polymer interaction. Carbon 2010, 48, 3551-3558.
32. Takeda T, Shindo Y, Kuronuma Y, Narita F. Modeling and characterization of the electrical conductivity of carbon-based polymer composites. Polymer 2011, 52, 3852-3856.
33. Yoshino K, Kawagishi S, Lee S, Nakayama K, Take H, Kaji H. Electrical and optical properties of conducting polymer and carbons in nano-scale periodic structure and their intercalation effects. Mol. Cryst. Liq. Cryst. Sci. Technol. A 2000, 341, 485-490.
34. Geetha S, Rao CRK, Vijayan M, Trivedi DC. Biosensing and drug delivery by polypyrrole. Anal. Chim. Acta 2006, 568, 119-125.
35. Ravichandran R, Sundarrajan S, Venugopal JR, Mukherjee S, Ramakrishna S. Applications of conducting polymers and their issues in biomedical engineering, J. R. Soc. Interface 2010, 7, S559-S579.
36. Guimard NK, Gomez N, Schmidt CE. Conducting polymers in biomedical engineering. Prog. Polym. Sci. 2007, 32, 876-921.
37. Wadhwa R, Lagenaur, CF, Cui XT. Electrochemically controlled release from conducting polymer coated electrode. J. Control. Release 2006, 110, 531-541.
38. Abidian MZ, Kim DH, Martin DC. Conductive-polymer nanotubes for controlled drug release. Adv. Mater. 2006, 17, 405-409.
39. Luo X, Cui XT. Electrochemically controlled release based on nanoporous conducting polymers. Electrochem. Commun. 2009, 11, 402-404.
40. Sun Y, Xia Y. Gold and silver nanoparticles: a class of chromophores with colors tunable in the range from 400 to 750 nm. Analyst 2003, 128, 686-691.
41. Nobile C, Kudera S, Fiore A, Carbone L, Chilla G, Kipp T, Heitmann D, Cingolani R, Manna L, Krahne R. Confinement effects on optical phonons in spherical, rod-, and tetrapodshaped nanocrystals detected by Raman spectroscopy. Phys. Stat. Solidi A: Appl. Mater. Sci. 2007, 204, 483-486.
42. Xu X, Cortie MB. Shape change and color gamut in gold nanorods, dumbbells, and dog bones. Adv. Funct. Mater. 2006, 16, 2170-2176.
43. He YQ, Liu SP, Kong L, Liu ZF. A study on the sizes and concentrations of gold nanoparticles by spectra of absorption, resonance Rayleigh scattering and resonance non-linear scattering. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2005, 61, 2861-2866.
44. Hu M, Chen J, Li ZY, Au L, Hartland GV, Li X, Marquez M, Xia Y. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 2006, 35, 1084-1094.
45. Hirsch LR, Gobon AM, Lowery AR, Tam F, Drezek RA, Halas NJ, West JL. Metal nanoshells. Ann. Biomed. Eng. 2006, 34, 15-22.
46. Aizpurua J, Hanarp P, Sutherland DS, K a ll M, Bryant GW, De Abajo FJG. Optical properties of gold nanorings. Phys. Rev. Lett. 2003, 90, 057401-1-057401-5.
47. Haes AJ, Stuart DA, Nie S, van Duyne RP. Using solutionphase nanoparticles, surface-confined nanoparticles arrays and single nanoparticles as biological sensing platforms. J. Fluoresc. 2004, 14, 355-367.
48. Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J, Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 2004, 3, 33-40.
49. Govorov AO, Richardson HH. Generating heat with metal nanoparticles. Nano Today 2007, 2, 30-38.
50. Liao H, Nehl CL, Hafner JH. Biomedical applications of plasmon resonant metal nanoparticles. Nanotechnology 2006, 1, 201-208.
51. You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano 2010, 4, 1033-1041.
52. Quenten M. The color of finely dispersed nanoparticles. Appl. Phys. B: Lasers Opt. 2001, 73, 317-326.
53. Jain PK, El-Sayed IH, El-Sayed MS. Au nanoparticles target cancer. Nano Today 2007, 2, 18-29.
54. Hatta I. Thermal characteristics in a nanometer scale. J. Therm. Anal. Calorim. 2002, 69, 717-725.
55. Chen G. Particularities of heat conduction in nanostructures. J. Nanopart. Res. 2000, 2, 199-204.
56. Michel M, Gemmer J, Mahler G. Microscopic quantum mechanical foundation of Fouriers's Law. Int. J. Mod. Phys. B 2006, 1, 1-30.
57. Lepri S, Livi R, Politi A. Thermal conduction in classical low-dimensional lattices. Phys. Rep. 2003, 377, 1-80.
58. Kim W, Wang R, Majumdar A. Nanostructuring expands thermal limits. Nano Today 2007, 2, 40-47.
59. Tien CL, Chen G. Challenges in microscale conductive and radiative heat transfer. J. Heat Trans. 1994, 116, 799-807.
60. Cenian A, Gabriel H. Ballistic energy transfer in dielectric Ar crystals. J. Phys .: Condens. Matter 2001, 13, 4323-4339.
61. Chen G. Ballistic-diffusive equations for transient heat conduction from nano to macroscales. J. Heat Trans. 2002, 124, 320-328.
62. Gomes CJ, Madrid M, Goicochea JV, Amon CH. In-plane and out-of-plane thermal conductivity of silicon thin films predicted by molecular dynamics. J. Heat Trans. 2006, 128, 1114-1121.
63. Chen G. Nonlocal and nonequilibrium heat conduction in the vicinity of nanoparticles. J. Heat Transfer 1996, 118, 539-545.
64. Rieger J, Horner D. Organic nanoparticles in the aqueous phase-theory, experiment, and use. Angew. Chem. Int. Ed. Engl. 2001, 40, 4330-4361.
65. Diao Y, Helgeson ME, Myerson AS, Hatton TA, Doyle PS, Trout BL. Controlled nucleation from solution using polymer microgels. J. Am. Chem. Soc. 2011, 133, 3756-3759.
66. Diao Y, Myerson AS, Hatton TA, Trout BL. Surface design for controlled crystallization: the role of surface chemistry and nanoscale pores in heterogeneous nucleation. Langmuir 2011, 27, 5324-5334.
67. Ha JM, Wolf JH, Hillmyer MA, Ward MD. Polymorph selection under nanoscopic confinement. J. Am. Chem. Soc. 2004, 126, 3382-3383.
68. Oxtoby DW. Nucleation of first-order phase transitions. Acc. Chem. Res. 1998, 31, 91-97.
69. Kim K, Centrone A, Hatton TA, Myerson AS. Polymorphism control of nanosized glycine crystals on engineered surfaces. Cryst. Eng. Comm. 2011, 13, 1127-1131.
70. Mannsfeld SCB, Briseno AL, Liu S, Reese C, Roberts ME, Bao Z. Selective nucleation of organic single crystals from vapor phase on nanoscopically rough surfaces. Adv. Funct. Mater. 2007, 17, 3545-3553.
71. Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. 1990, 29, 138-175.
72. Naka K, Tanaka Y, Chujo Y. Effect of anionic starburst dendrimers on the crystallization of CaCO 3 in aqueous solution: size control of spherical vaterite particles. Langmuir 2002, 18, 3655-3658.
73. Wu T, Sun Y, Li N, De Villiers MM, Yu L. Inhibiting surface crystallization of amorphous indomethacin by nanocoating. Langmuir 2007, 23, 5148-5153.
74. Zhang Z, Zhao M, Jiang Q. Glass transition thermodynamics of organic nanoparticles. Physica B 2001, 293, 232-236.
75. Jiang Q, Shi HX, Li JC. Finite size effect on glass transition temperatures. Thin Solid Films 1999, 354, 283-286.
76. Koh YP, McKenna GB, Simon SL. Calorimetric glass transition temperature and absolute heat capacity of polystyrene ultrathin films. J. Polym. Sci. Part B, Polym. Phys. 2006, 44, 3518-3527.
77. Bares J. Glass transition of the polymer microphase. Macromolecules 1975, 8, 244-246.
78. Fox TG, Flory PJ. Second-order transition temperatures and related properties of polystyrene. I. Influence of the molecular weight. J. Appl. Phys. 1950, 21, 581-591.
79. Jackson CL, McKenna GB. Vitrification and crystallization of organic liquids confined to nanoscale pores. Chem. Mater. 1996, 8, 2128-2137.
80. MacFarlane DR, Angell CA. An emulsion technique for the study of marginal glass formation in molecular liquids. J. Phys. Chem. 1982, 86, 1927-1930.
81. Alba C, Busse LE, List DJ, Angell CA. Thermodynamic aspects of the vitrification of toluene, and xylene isomers, and the fragility of liquid hydrocarbons. J. Chem. Phys. 1990, 92, 617-624.
82. Xiong XY, Tam KC, Gan LH. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J. Control. Release 2005, 103, 73-82.
83. Missirlis D, Hubbell JA, Tirelli N. Thermally-induced glass formation from hydrogel nanoparticles. Soft Matter 2006, 2, 1067-1075.
84. Jiang Q, Yang CC, Li JC. Melting enthalpy depression of nanocrystals. Mater. Lett. 2002, 56, 1019-1021.
85. Liang LH, Zhao M, Jiang Q. Melting enthalpy depression of nanocrystals based on surface effect. J. Mater. Sci. Lett. 2002, 21, 1843-1845.
86. Shrivastava KN. Melting temperature, Brillouin shift, and density of states of states of nanocrystals. Nano Lett. 2002, 2, 519-523.
87. Xue Y, Zhao Q, Luan C. The thermodynamic relations between the melting point and the size of crystals. J. Colloid Interface Sci. 2001, 243, 388-390.
88. Qi WH. Size effect on melting temperature of nanosolids. Physica B 2005, 368, 46-50.
89. Guinea F, Rose JR, Smith JR, Ferrante J. Scaling relations in the equation of state, thermal expansion, and melting of metals. Appl. Phys. Lett. 1984, 44, 53-55.
90. Buffat P, Borel JP. Size effect on the melting temperature of gold particles. Phys. Rev. A: At. Mol. Opt. Phys. 1976, 13, 2287-2298.
91. Guisbiers G, Wautelet M. Size, shape and stress effects on the melting temperature of nano-polyhedral grains on a substrate. Nanotechnology 2006, 17, 2008-2011.
92. Wang XW, Fei GT, Zheng K, Jin Z, Zhang LD. Size-dependent melting behavior of Zn nanowire arrays. Appl. Phys. Lett. 2006, 88, 173114-1-173114-3.
93. Zhang Z, Li JC, Jiang Q. Modelling for size-dependent and dimension-dependent melting of nanocrystals. J. Phys. D: Appl. Phys. 2000, 33, 2653-2656.
94. Wautelet M, Dauchot JP, Hecq M. Size effects on the phase diagrams of nanoparticles of various shapes. Mater. Sci. Eng. C 2003, 23, 187-190.
95. Wautelet M. On the shape dependence of the melting temperature of small particles. Phys. Lett. A 1998, 246, 341-342.
96. Sun CQ, Li CM, Bai HL, Jiang EY. Melting point oscillation of a solid over the whole range of sizes. Nanotechnology 2005, 16, 1290-1293.
97. Jiang Q, Shi HX, Zhao M. Melting thermodynamics of organic nanocrystals. J. Chem. Phys. 1999, 111, 2176-2180.
98. Mottet C, Rossi G, Baletto F, Ferrando R. Single impurity effect on the melting of nanoclusters. Phys. Rev. Lett. 2005, 95, 035501-1-035501-4.
99. Bergese P, Colombo I, Gervasoni D, Depero LE. Melting of nanostructured drugs embedded into a polymeric matrix. J. Phys. Chem. B 2004, 108, 15488-15493.
100. Shirinyan AS, Wautelet M. Phase separation in nanoparticles. Nanotechnology 2004, 15, 1720-1731.
101. Shirinyan AS, Gusak AM, Wautelet M. Phase diagrams versus diagram of solubility: what is the difference for nanosystems ? Acta Mater. 2005, 53, 5025-5032.
102. Dalnoki-Veress K, Forrest JA, Murray C, Cigault C, Dutcher JR. Molecular weight dependence of reductions in the glass transition temperature of thin, freely standing polymer films. Phys. Rev. E: Stat., Nonlinear, Soft Matter Phys. 2001, 031801-1-031801-10.
103. Mihranyan A, Stromme M. Solubility of fractal nanoparticles. Surf. Sci. 2007, 601, 315-319.
104. Hildebrandt JH. Solubility. XII. Regular solutions. J. Am. Chem. Soc. 1929, 51, 66-80.
105. Yalkowsky SH, Valvani SC. Solubility and partitioning I: solubility of nonelectrolytes in water. J. Pharm. Sci. 1980, 69, 912-922.
106. Amidon GL, Yalkowsky SH, Leung S. Solubility of nonelectrolytes in polar solvents II: solubility of aliphatic alcohols in water. J. Pharm. Sci. 1974, 63, 1858-1866.
107. Berg JC. An Introduction to Interfaces and Colloids. The Bridge to Nanoscience. World Scientific Publishing: New Jersey, 2010.
108. Bisrat M, Nystr o m C. Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions. Int. J. Pharm. 1988, 47, 223-231.
109. Galvin KP. A conceptually simple derivation of the Kelvin equation. Chem. Eng. Sci. 2005, 60, 4659-4660.
110. Nanda KK, Maisels A, Kruis FE, Fissan H, Stappert S. Higher surface energy of free nanoparticles. Phys. Rev. Lett. 2003, 91, 106102-1-106102-4.
111. Smolen VF, Kildsig DO. Vapor pressure and solubility of small particles. Am. J. Pharm. Ed. 1967, 31, 512-514.
112. Ouyang G, Tan X, Wang CX, Yang GW. Solid solubility limit in alloying nanoparticles. Nanotechnology 2006, 17, 4257-4262.
113. Tang R, Wang L, Nancollas GH. Size-effects in the dissolution of hydroxyapatite: an understanding of biological demineralization. J. Mater. Chem. 2004, 14, 2341-2346.
114. Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 2004, 284, 109-122.
115. Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897, 19, 930-934.
116. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. I. Theoretical consideration. Ind. Eng. Chem. 1931, 23, 923-931.
117. Tinke AP, Vanhoutte K, de Maesschalck R, Verheyen S, de Winter H. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution. J. Pharm. Biomed. Anal. 2005, 39, 900-907.
118. Anderberg EK, Bisrat M, Nystr o m C. Physicochemical aspects of drug release. VII The effect of surfactant concentration and drug particle size on solubility and dissolution rate of felodipine, a sparingly soluble drug. Int. J. Pharm. 1988, 47, 67-77.
119. Galli C. Experimental determination of the diffusion boundary layer width of micron and submicron particles. Int. J. Pharm. 2006, 313, 114-122.
120. Heywood H. Particle shape coefficients. J. Imp. College Chem. Soc. 1954, 8, 25-33.
121. Mosharraf M, Nytsr o m C. Effect of particle size and shape on the surface specific dissolution rate of micronized practically insoluble drugs. Int. J. Pharm. 1995, 122, 35-47.
122. Zhang H, Gilbert B, Huang F, Banfield JF. Water-driven structure transition in nanoparticles at room temperature. Nature 2003, 424, 1025-1029.
123. Sdobnyakov NY, Samsonov VM. On the size dependence of surface tension in the temperature range from melting point to critical point. Cent. Eur. J. Phys. 2005, 3, 247-257.
124. Powell C, Fenwick N, Bresme F, Quirke N. Wetting of nanoparticles and nanoparticle arrays. Colloids Surf. A 2002, 206, 241-251.
125. Liu Y, Chen X, Xin JH. Super-hydorphobic surface from a simple coating: a bionic nanoengineering approach. Nanotechnology 2006, 17, 3259-3263.
126. Crisp MW, Tucker CJ, Rogers TL, Williams RO, Johnston KP. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanoparticles. J. Control. Release 2007, 117, 351-359.
127. Bisrat M, Anderberg EK, Barnett MI, Nystr o m C. Physicochemical aspects of drug release. XV. Investigation of diffusional transport in dissolution of suspended, sparingly soluble drugs. Int. J. Pharm. 1992, 80, 191-201.
128. Aharoni C. The solid-liquid interface in capillary condensation. Sorption of water by active carbons. Langmuir 1997, 13, 1270-1273.
129. Aharoni C. Effect of the energy of adsorption at the pore wall surface on capillary condensation. Langmuir 2002, 18, 7441-7446.
130. Aharoni C. Adsoprtion and condensation in pores. Langmuir 1998, 14, 3339-3342.
131. Dobruskin VK. Correlation between saturation pressures and dimensions of nanoparticles. Are the fundamental equations really fair ? L angmuir 2003, 19, 4004-4013.
132. Germain J, Hradil J, Fr e chet JMJ, Svec F. High surface area nanoporous polymers for reversible hydrogen storage. Chem. Mater. 2006, 18, 4430-4435.
133. Aranovich GL, Donohue MD. The role of adsorption compression in nanocapillaries. J. Colloid Interface Sci. 2005, 292, 202-209.
134. Brovchenko I, Geiger A, Oleinikova A. Water in nanopores. I. Coexistence curves from Gibbs ensemble Monte Carlo simulations. J. Chem. Phys. 2004, 120, 1958-1972.
135. Ravikovitch PI, Neimark AV. Experimental confirmation of different mechanisms of evaporation from ink-bottle type pores: equilibrium, pore blocking, and cavitation. Langmuir 2002, 18, 9830-9837.
136. Stillinger FH. Structure in aqueous solutions of nonpolar solutes from the standpoint of scaled-particle theory. J. Sol. Chem. 1973, 2, 141-158.
137. Luzar A. Activation barrier scaling for the spontaneous evaporation of confined water. J. Phys. Chem. B 2004, 108, 19859-19866.
138. Lum K, Luzar A. Pathway to surface-induced phase transition of a confined fluid. Phys. Rev. E: Stat. Nonlinear Soft Matter Phys. 1997, 56, R6283-R6286.
139. Leung K, Luzar A, Bratko D. Dynamics of capillary drying in water. Phys. Rev. Lett. 2003, 90, 065502-1-065502-4.
140. Maeda N, Israelachvili JN. Nanoscale mechanisms of evaporation, condensation and nucleation in confined geometries. J. Phys. Chem. B 2002, 106, 3534-3537.
141. Beckstein O, Biggin PC, Sansom MSP. A hydrophobic gating mechanism for nanopores. J. Phys. Chem. B 2001, 105, 12902-12905.
142. Sansom MSP, Biggin PC. Water at the nanoscale. Nature 2001, 414, 156-159.
143. Beckstein O, Tai K, Sansom MSP. Not ions alone: barriers to ion permeation in nanopores and channels. J. Am. Chem. Soc. 2004, 126, 14694-14695.
144. Allen R, Melchionna S, Hansen JP. Intermittent permeation of cylindrical nanopores by water. Phys. Rev. Lett. 2002, 89, 175502-1-4.
145. Allen R, Hansen JP, Melchionna S. Molecular dynamics investigation of water permeation through nanopores. J. Chem. Phys. 2003, 119, 3905-3919.
146. Truskett TM, Debenedetti PG, Torquato S. Thermodynamic implications of confinement for a waterlike fluid. J. Chem. Phys. 2001, 114, 2401-2418.
147. Celestini F. Capillary condensation within nanopores of various geometries. Phys. Lett. A 1997, 228, 84-90.
148. Ramirez P, Mafe S, Alcaraz A, Cervera J. Modeling the pH-switchable ion transport and selectivity in nanopores membranes with fixed charges. J. Phys. Chem. B 2003, 107, 13178-13187.
149. Leung K, Rempe SB, Lorenz CD. Salt permeation and exclusion in hydroxylated and functionalized silica pores. Phys. Rev. Lett. 2006, 96, 095504-1-095504-1-4.
150. Asefa T, Otuonye AN, Wang G, Blair EA, Vathyam R, Denton K. Controlling adsorption of drug and small molecules by organic functionalization of mesoporous materials. Adsorption 2009, 15, 287-299.
151. Vathyaman R, Wondimu E, Das S, Zhang C, Hayes S, Tao Z, Asefa T. Improving the adsorption and release capacity of organic-functionalized mesoporous materials to drug molecules with temperature and synthetic methods. J. Phys. Chem. C 2011, 115, 13135-13150.
152. Br a s AR, Merino EG, Neves PD, Fronseca IM, Dion i so M, Sch o nhals A, Correia NT. Amorphous ibuprofen confined in nanostructured silica materials: a dynamical approach. J. Phys. Chem. C 2011, 115, 4616-4623.
153. Kim MH, Ayral A, Park CB, Choy JH, Oh JM. Diffusion control of porous membrane by modifying pore properties. J. Nanosci. Nanotechnol. 11, 1656-1659.
154. Berg MC, Zhai L, Cohen RE, Rubner MF. Controlled drug release from porous polyelectrolyte multilayers. Biomacromolecules 2006, 7, 357-364.
155. Vaccari L, Canton D, Zaffaroni N, Villa R, Tormen M, di Fabrizio E. Porous silicon as carrier for controlled delivery of doxorubicin anticancer agent. Microelectron. Eng. 2006, 83, 1598-1601.
156. Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y, Zhu G. pH-triggered controlled drug release from mesoporous silica nanoparticles via intracellular dissolution of ZnO nanolids. J. Am. Chem. Soc. 2011, 133, 8778-8781.
157. Hong Y, Chen X, Jing X, Fan H, Guo B, Gu Z, Zhang X. Preparation, bioactivity, and drug release of hierarchical nanoporous bioactive glass ultrathin fibers. Adv. Mater. 2010, 22, 754-758.
158. Ambrogi V, Perioli L, Marmottini F, Accorso O, Cinzia P, Ricci M, Rossi C. Role of mesoporous silicates on carbamazepine dissolution rate enhancement. Microporous Mesoporous Mater. 2008, 113, 445-452.
159. Rengarajan GT, Enke D, Steinhart M, Beiner M. Stabilization of the amorphous state of pharmaceuticals in nanopores. J. Mater. Chem. 2008, 18, 2537-2539.
160. Lo KH, Chen MC, Ho RM, Sung HS. Pore-filling nanoporous templates from degradable block copolymers for nanoscale drug delivery. ACS Nano 2009, 3, 2660-2666.
161. Signoretto M, Ghedini E, Nichele V, Pinna F, Crocell a V, Cerrato G. Effect of textural properties on the drug delivery behavior of nanoporous TiO 2 matrices. Microporous Mesoporous Mater. 2011, 139, 189-196.
162. Chaban VV, Prezhdo OV. Water boiling inside carbon nanotubes: toward efficient drug releae. ACS Nano 2011, 5, 5647-5655.
163. Alleman E, Gurny R, Doelker E. Drug-loaded nanoparticles. Preparation methods and targeting issues. Eur. J. Pharm. Biopharm 1993, 39, 173-191.
164. Chorny M, Fishbein I, Haim D, Golomb G. Study of the drug release mechanism from yrphostin AG-1295-loaded nanospheres by in situ and external sink methods. J. Control. Release 2002, 83, 401-414.
165. Lecaroz C, Gamazo C, Renedo MJ, Blanco-Prieto MJ. Biodegradable micro-and nanoparticles as long-term delivery vehicles for gentamicin. J. Microencapsul. 2006, 23, 782-789.
166. Beck RCR, Pohlmann AR, Guterres SS. Nanoparticlecoated microparticles: preparation and characterization. J. Microencapsul. 2004, 21, 499-512.
167. Bapat N, Boroujerdi M. Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effects of methods of preparation. Drug Dev. Ind. Pharm. 1992, 18, 65-77.
168. Illum L, Khan MA, Mak E, Davis SS. Evaluation of carrier capacity and release characteristics of poly(butyl 2-cyanoacrylate) nanoparticles. Int. J. Pharm. 1986, 30, 17-28.
169. Lopes E, Pohlmann AR, Bassani V, Guterres SS. Polymeric colloidal systems containing ethionamide: preparation and physic-chemical characterization. Pharmazie 2000, 55, 527-530.
170. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70, 1-20.
171. Opanasopit P, Ngawhirunpat T, Chaidedgumjorn A, Rojanarata T, Apirakaramwong A, Phongying S, Choochottiros C, Chirachanchai S. Incorporation of camptothecin into N-phtaloyl chitosan chitosan-g-mPEG self-assembly micellar systems. Eur. J. Pharm. Biopharm. 2006, 64, 269-276.
172. Bhattarai N, Ramay HR, Chou SH, Zhang M. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int. J. Pharm. 2006, 1, 181-187.
173. Govender T, Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, Davis SS. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm. 2000, 199, 95-110.
174. Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E. A new class of silica cross-linked micellar core-shell nanoparticles. J. Am. Chem. Soc. 2006, 128, 6447-6453.
175. Jiang B, Hu L, Gao C, Jiacong S. Ibuprofen-loaded nanoparticles prepared by a co-precipitation methods and their release properties. Int. J. Pharm. 2005, 304, 220-230.
176. Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. Int. J. Pharm. 2005, 301, 268-276.
177. Patri AK, Kukowska-Latallo JF, Baker JR. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Deliv. Rev. 2005, 57, 2203-2214.
178. Kolhe P, Misra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int. J. Pharm. 2003, 259, 143-160.
179. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 1999, 57, 171-185.
180. Gaber NN, Darwis Y, Peh KK, Tan YTF. Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate. J. Nanosci. Nanotechnol. 2006, 6, 3095-3101.
181. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52, 1145-1149.
182. Zhang J, Xiang L, Xiao J, Qiu L, Yan L, Xiao H, Yan MQJ, Yi J, Zhu KJ. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly ( N-isopropylacrylamide) and ethyl tryptophan as side groups: preparation, in vitro and in vivo evaluation. J. Control. Release 2006, 116, 322-329.
183. Guy RH, Hadgraft J, Kellaway IW, Taylor JM. Calculations of drug release from spherical particles. Int. J. Pharm. 1982, 11, 199-207.
184. Ritger PL, Peppas NA. A simple equation for description of solute release. 1. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks. J. Control. Release 1987, 5, 23-36.
185. Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release 1987, 5, 37-42.
186. Leo E, Scatturin A, Vighi E, Dalpiaz A. Polymeic nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight. J. Nanosci. Nanotech. 2006, 6, 3070-3079.
187. Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Deliv. Rev. 2001, 48, 229-247.
188. Siepmann J, Faisant N, Benoit JP. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm. Res. 2002, 19, 1885-1893.
189. Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano-and microparticles. J. Control. Release 2003, 92, 173-187.
190. Jo YS, Kim MC, Kyung D, Kim CJ, Jeong YK, Kim KJ, Muhammed M. Mathematical modeling on the controlled-release of indomethacin-encapsulated poly(lactic acid-co-ethylene oxide) nanospheres. Nanotechnology. 2004, 15, 1186-1194.
191. Polakovic M, Gorner T, Gref R, Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J. Control. Release 1999, 60, 169-177.
192. Zur M u hlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 1998, 53, 552-555.
193. Sukhorukov GB, Fery A, Brumen M, M o hwald H. Physical chemistry of encapsulation and release. Phys. Chem. Chem. Phys. 2004, 6, 4078-4089.
194. De Geest BG, Sanders NN, Sukhorukov GB, Demeester J, De Smedt SC. Release mechanisms for polyelectrolyte capsules. Chem. Soc. Rev. 2007, 36, 636-649.
195. Johnston APR, Cortez C, Angelatos AS, Caruso F. Layer-bylayer engineered capsules and their applications. Curr. Opin. Colloid Interface Sci. 2006, 203-209.
196. Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactideco-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation. J. Control. Release 2001, 70, 353-363.
197. Gref R, Quellec P, Sanchez A, Calvo P, Dellacherie E, Alonso MJ. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol) PEG micro-and nanoparticles. Comparison with conventional PLA particulate carriers. Eur. J. Pharm. Biopharm. 2001, 51, 111-118.
198. Lu XY, Zhang Y, Wang L. Preparation and in vitro drug-release behavior of 5-fluorouracil-loaded poly(hydroxybutyrate-co-hydroxyhexanoate) nanoparticles and nanoparticles. J. Appl. Polym. Sci. 2010, 116, 2944-2950.
199. Chakravarthi SS, De S, Miller DW, Robinson DH. Comparison of anti-tumor efficacy of paclitaxel delivered in nano-and microparticles. Int. J. Pharm. 2010, 383, 37-44.
200. Paraj o Y, d'Angelo I, Horv a th A, Vantus T, Gy o rgy K, Welle A, Garcia-Fuentes M, Alonso MJ. PLGA:poloxamer blend micro-and nanoparticles as controlled release systems for synthetic proangiogenic factors. Eur. J. Pharm. Sci. 2010, 41, 644-649.
201. Miao ZM, Cheng SX, Zhang XZ, Zhuo RX. Study on drug release behaviors of poly-a,ß-[ N-(2-hydroxyethyl)-L-aspartamide]-g-poly(e-caprolactone) nano-and microparticles. Biomacromolecules 2006, 7, 2020-2026.
202. Hasan AS, Socha M, Lamprecht A, Ghazouani FE, Sapin A, Hoffman M, Maincent P, Ubrich N. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int. J. Pharm. 2007, 344, 53-61.
203. Sigfridsson K, Nordmark A, Theilig S, Lindahl A. A formulation comparison between micro-and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development. Drug Dev. Ind. Pharm. 2011, 37, 185-192.
204. Tsai M, Lu Z, Wang J, Yeh TK, Wientjies MG, Au JLS. Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel. Pharm. Res. 2007, 24, 1691-1701.